Doctor profile · Federal record

Dr. Seema Malani, MD

Rheumatology Physician (CMS: Rheumatology) · Katy, TX

  • NPI 1417189325
  • Accepts Medicare
  • MIPS 89.7 / 100 · 2023
  • 26 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
2630 N Mason RD Ste A2
Katy, TX 774493059
(281) 712-8360
fax (281) 712-8361
Mailing address
777 S Fry RD, #103
Katy, TX 774502244

Credentials & registration

NPPES · NUCC
NPI registered
August 2009 — 17 yrs on file
Profile last updated
November 13, 2019
Year of graduation
2000 — 26 yrs since
Specialty taxonomy
207RR0500X — NUCC code
State license (1)
Texas #N8033

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1417189325. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
148,859
Distinct HCPCS
10
Medicare allowed
$1,526,193
HCPCS Description Services Patients Avg allowed
J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 126,400 41 $5
J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 10,050 15 $42
J1745 Injection, infliximab, excludes biosimilar, 10 mg 6,170 16 $33
J0897 Injection, denosumab, 1 mg 3,960 41 $23
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle 698 78 $74
99214 Established patient office or other outpatient visit, 30-39 minutes 479 247 $129
96413 Administration of chemotherapy into vein, 1 hour or less 205 43 $133
96415 Administration of chemotherapy into vein, each additional hour 198 22 $29
96372 Injection of drug or substance under skin or into muscle 134 17 $14
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less 127 14 $65

In context: peer comparison

Among 5 peers in Katy Rheumatology Physician, average services per provider: 5,088. This provider delivers 29× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$290
Transactions
8
Manufacturers
3
Payer (manufacturer) Industry Txns Amount
Amgen INC. 5 $210.71
Ucb, INC. 2 $51.74
Janssen Biotech, INC. 1 $27.79

By nature of payment

Food and Beverage
$290

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
4,094
Patients
1,346
Total drug cost
$987,695
Drug Type Claims Patients Total cost
Methotrexate (Methotrexate Sodium) Brand 678 200 $25,695
Prednisone Generic 521 195 $3,408
Gabapentin Generic 386 111 $8,893
Hydroxychloroquine Sulfate Generic 386 129 $24,446
Tramadol Hcl Generic 341 86 $2,140
Duloxetine Hcl Generic 330 100 $7,248
Meloxicam Generic 251 111 $970
Leflunomide Generic 205 73 $15,596
Celecoxib Generic 203 77 $5,331
Tizanidine Hcl Generic 171 78 $1,337

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Seema Malani's medical specialty?
Dr. Seema Malani practices Rheumatology Physician in Katy, TX.
Where does Dr. Seema Malani practice?
Dr. Seema Malani practices at 2630 N Mason RD Ste A2, Katy, TX 774493059. Office phone: 2817128360.
What is Dr. Seema Malani's NPI?
Dr. Seema Malani's National Provider Identifier (NPI) is 1417189325, issued by NPPES.
Does Dr. Seema Malani accept Medicare assignment?
Yes. Dr. Seema Malani accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Seema Malani commonly perform?
Top Medicare-reported procedures in 2023: Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0717); Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0129); Injection, infliximab, excludes biosimilar, 10 mg (HCPCS J1745). Source: CMS Medicare Physician & Other Practitioners file.